Centiva Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,508
| Closed | -$505K | – | 1329 |
|
|
2024
Q3 | $505K | Buy |
+1,508
| New | +$505K | 0.01% | 805 |
|
|
2023
Q3 | – | Sell |
-755
| Closed | -$286K | – | 1235 |
|
|
2023
Q2 | $286K | Buy |
755
+18
| +2% | +$6.82K | 0.01% | 779 |
|
|
2023
Q1 | $353K | Buy |
+737
| New | +$353K | 0.01% | 625 |
|
|
2022
Q2 | – | Sell |
-952
| Closed | -$536K | – | 1233 |
|
|
2022
Q1 | $536K | Buy |
+952
| New | +$536K | 0.01% | 573 |
|
|
2021
Q3 | – | Sell |
-1,124
| Closed | -$724K | – | 947 |
|
|
2021
Q2 | $724K | Buy |
1,124
+756
| +205% | +$487K | 0.02% | 416 |
|
|
2021
Q1 | $210K | Buy |
+368
| New | +$210K | 0.01% | 744 |
|